Get the Stockscreener App
2.2001
8.71%
-0.21
After Hours:
2.20
-0.000100
-0.00%
X T L Biopharmaceuticals Ltd Adr stock is traded at $2.2001, with a volume of 1,039.
It is down -8.71% in the last 24 hours and down -15.38% over the past month.
XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.
See More
Previous Close:
$2.4101
Open:
$2.3
24h Volume:
1,039
Relative Volume:
0.05
Market Cap:
$5.41M
Revenue:
$453.80K
Net Income/Loss:
$-1.03M
P/E Ratio:
-3.0625
EPS:
-0.7184
Net Cash Flow:
-
1W Performance:
-8.33%
1M Performance:
-15.38%
6M Performance:
-18.82%
1Y Performance:
-88.44%
1-Day Range:
$2.2001
$2.43
1-Week Range:
$2.1859
$2.50
52-Week Range:
$2.0101
$41.12
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Name
X T L Biopharmaceuticals Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare XTLB vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
2.2001 | 5.41M | 453.80K | -1.03M | 0 | -0.7184 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-08-15 | Initiated | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Latest News
XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceLiquidity Sweep - dars.gov.et
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition - TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail
XTLB Stock Price, Quote & Chart - ChartMill
Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks
Wondering what's happening in today's after-hours session? - ChartMill
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks
XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat
XTLB - Finviz
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks
XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com
Eastern International Ltd. expands board, appoints two new directors - Investing.com
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail
SMX increases authorized shares for incentive plan and grants restricted stock units - Investing.com
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks
XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake - Investing.com
Triangle DescendingStock ScreenerCharts - Finviz
Top GainersStock ScreenerSnapshot - Finviz
XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown
Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView
Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView
Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView
EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView
Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView
Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView
Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView
Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView
XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView
Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):